The distinction of Fellowship in SIDP (FIDP) recognizes outstanding SIDP members with significant and sustained contributions to infectious diseases and the mission of SIDP. Successful applicants demonstrate a commitment to promoting the appropriate use of antimicrobials for the prevention and management of infectious diseases through leadership and collaboration in infectious diseases practice, education, research, and advocacy. Nominees complete an application and provide supporting documentation, which are reviewed and scored by the Recognition Awards Committee. Successful applicants must demonstrate excellence in the area of Contributions to SIDP and at least two of the following categories: practice, education, or scholarship.
Please consider nominating a colleague for this distinction, which is awarded at the SIDP Business Meeting and Lecture Series in the fall. Further information regarding the nomination and application process can be found here. |
2024 Recipients
Lisa Dumkow, PharmD, FIDP, BCIDP Dr. Lisa Dumkow, PharmD, BCIDP is a Clinical Pharmacist Specialist in Antimicrobial Stewardship and the Program Director of the PGY2 Infectious Diseases Pharmacy Residency Program at Trinity Health Grand Rapids Hospital in Grand Rapids, MI. Dr. Dumkow received her Doctor of Pharmacy degree from the University of Toledo College of Pharmacy in Toledo, OH and then completed both her PGY1 and PGY2 infectious diseases residency training at Henry Ford Hospital in Detroit, MI. In her over a decade-long career at Trinity Health Grand Rapids, Dr. Dumkow has created a diverse practice centered around a culture of antimicrobial stewardship in both inpatient and outpatient settings. She has spearheaded innovative programs including pharmacist-led ED and Urgent Care culture follow-up programs. She has authored more than 40 peer-reviewed publications and is a past recipient of the Michigan Society of Health System-Pharmacists’ Best Practice Award. Dr. Dumkow has consistently contributed to SIDP since first joining as a trainee member in 2012, serving on both the Stewardship and Programs Committees. She has most recently served on the Programs Committee leadership team (2020-2023), including serving as Chair in 2022 during the first live IDWeek meeting where SIDP was a partner society. Dr. Dumkow also serves as the SIDP representative for the IDWeek Programming Committee as a member of the Stewardship Subcommittee (2023-present). Other notable contributions to SIDP include co-authoring on the ASHP/SIDP Joint Statement on the Pharmacist's Role in Antimicrobial Stewardship, serving a panelist for a Breakpoints podcast series, and volunteering as a mentor for the DEI mentorship program. She was recently elected as the President-Elect of SIDP. Dr. Dumkow is proud to call SIDP her professional home and continues to be grateful for the opportunities and relationships she has had and continues to form through her involvement within the Society. |
Vincent H. Tam, PharmD, FIDSA, FIDP Vincent Tam received a B.S. from the National University of Singapore, Singapore and his Pharm.D. from Albany College of Pharmacy in Albany, New York. He completed an infectious diseases pharmacy residency at Detroit Receiving Hospital in Detroit, Michigan and a clinical pharmacology / infectious diseases fellowship at Albany Medical College. He is currently a Professor (tenured) at the University of Houston College of Pharmacy in Houston, Texas. He is board certified in infectious diseases pharmacy. Dr. Tam is the (co-) author of over 190 peer-reviewed publications in antimicrobial pharmacokinetics / pharmacodynamics and infectious disease therapeutics. He is on the Editorial Boards of Antimicrobial Agents and Chemotherapy, and Journal of Global Antimicrobial Resistance. He has also served as a grant proposal reviewer for the National Institutes of Health (NIH) and reviewer for over 20 journals such as the Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy, Journal of Clinical Pharmacology, and Lancet Infectious Diseases. Dr. Tam has been an active member of SIDP since 1999. He has served on different (e.g., inter-organization, programs, recognitions, research) committees, most notably the Board of Directors (2015-2017). He has also represented SIDP on the National Foundation for Infectious Diseases (NFID) Board of Directors from 2009 to 2015. Other contribution to SIDP includes co-authoring the International Consensus Guidelines for the Optimal Use of the Polymyxins (2019) on behalf of SIDP. |